-
The Prevention of Atrial Fibrillation After Cardioversion Trial was a placebo-controlled study comparing sotalol and a quinidine/verapamil combination in patients with persistent atrial fibrillation after cardioversion.
-
Low-dose aspirin is as effective as warfarin for preventing cerebral thromboembolic events after bioprosthetic aortic valve replacement.
-
The developing world is experiencing an epidemic of CAD which expects to continue to increase in the foreseeable future.
-
The use of automatic external defibrillators by trained volunteers is safe and effective, particularly in public locations where there is at least a moderate likelihood that an out-of-hospital cardiac arrest will be witnessed.
-
A calcium score < 100 eliminates the need for myocardial perfusion scans (MPS), but patients with a negative MPS often have coronary calcium. These findings imply a potential role for applying coronary artery calcium screening after MPS among patients manifesting normal MPS.
-
Issues July, August, and September 2004 were printed as Volume 21. They should read Volume 23.
-
-
A new, and as of yet unpublished study, has raised increased concern about the relationship between rofecoxib (Vioxx), Mercks blockbuster COX-2 inhibitor, and cardiovascular events. The study, which was presented at a meeting in Bordeaux France, was financed by the FDA in collaboration with Californias HMO giant Kaiser Permanente.
-
-
Elevated serum uric acid is a marker for
cardiovascular mortality.
